Clearwater Paper Corporation (CLW) Cash Flow Statement

Eight of ten quarters produced positive operating cash flow even though seven quarters reported net losses, which suggests that non-cash add-backs rather than trading profitability are supporting the cash line, a distinction that matters given the weak gross margins identified in the income statement review. Because working capital absorbed $98.8M cumulatively over the same window, the $312.8M earnings-to-cash gap appears to rest on non-cash charges whose composition investors should verify against the full periodic filings before treating operating cash flow as evidence of a turnaround.

FCF margin ranged from -17.6% in 2024Q4 to 15.8% in 2026Q2 before falling back to 4.1% in 2026Q3, and that dispersion indicates the recent positive quarters reflect timing effects in receivables and inventory rather than a durable step-change in earnings power. On a trailing basis the company has not self-funded its capital program from operations across this window, so the improvement in the last two quarters needs to persist for several more periods before the trajectory can be called improving.

Capital expenditure ran below depreciation in each of 2026Q1, 2026Q2 and 2026Q3, by $14.3M, $13.6M and $8.6M respectively, which may indicate that a heavy expansion phase concluded in 2024-25 and the company is now in a lighter investment cycle, though the maintenance-versus-growth split is not disclosed in the data provided. If spending settles near 3% of revenue while aging tissue and paperboard assets continue to depreciate at roughly $93M annually, replacement capital could eventually step back up and compress the modest free cash flow now being generated.

The largest drains, $64.6M in 2026Q3 and $62.1M in 2025Q2, were each followed or preceded by sharp reversals, a pattern that suggests quarter-to-quarter inventory and collection management rather than a structural improvement in the cash conversion cycle. This volatility makes any single quarter's operating cash flow a poor proxy for underlying performance, so analysts should weight trailing four-quarter sums and monitor whether the negative cumulative trend persists as revenue continues to contract.

After netting the $98.8M cumulative working capital drain, roughly $172.0M of other non-cash or accrual items, including $12.6M of stock-based compensation, must account for the remainder of the divergence, and their composition is not separately identified in the quarterly data supplied. The interpretation is material: if a meaningful share of that residual stems from impairments or deferred tax benefits rather than recurring operating accruals, the underlying cash generation may be weaker than the $114.6M headline implies, and the persistent gap between reported losses and positive cash flow warrants further investigation in the full financial statements.